Perfume Maker Givaudan’s Sales Beat Estimates, Tariff Paybacks Weigh on Shares
Givaudan’s second-quarter organic sales came in ahead of market estimates on Thursday, but its shares fell 5 percent on litigation costs and tariff repayments.

After months of political wrangling, Europe’s Parliament has reached a deal to significantly scale back landmark corporate sustainability rules, paving the way for much laxer environmental reporting and due diligence requirements for large fashion brands.

After months of political wrangling, Europe’s Parliament has reached a deal to significantly scale back landmark corporate sustainability rules, paving the way for much laxer environmental reporting and due diligence requirements for large fashion brands.

This season’s earnings paints a gloomy picture of the fiscal year ahead, thanks to a downturn in the US and a cooling fragrance market, but agile firms are finding brighter spots.

This season’s earnings paints a gloomy picture of the fiscal year ahead, thanks to a downturn in the US and a cooling fragrance market, but agile firms are finding brighter spots.

L’Oréal SA is selling at least €1.5 billion ($1.7 billion) of bonds in a three-part deal to help finance its acquisition of Kering Beauté.

L’Oréal SA is selling at least €1.5 billion ($1.7 billion) of bonds in a three-part deal to help finance its acquisition of Kering Beauté.

The company’CEO said on Wednesday it plans to sell Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.

The company’CEO said on Wednesday it plans to sell Novo Nordisk’s much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesity drugmaker.

Eight years after selling her prestige cosmetics line to Unilever Prestige, Janes has another brand on her hands, launching with 25 foundation shades and a face oil. Can lightning strike twice?

Eight years after selling her prestige cosmetics line to Unilever Prestige, Janes has another brand on her hands, launching with 25 foundation shades and a face oil. Can lightning strike twice?

The move deepens LVMH’s partnership with the high-end Swiss watch movement and component manufacturer.

The move deepens LVMH’s partnership with the high-end Swiss watch movement and component manufacturer.

The Japanese conglomerate’s sales dipped to a nine month low in its latest earnings, which accompanied sweeping changes to leadership and the unveiling of its newest action plan.

The Japanese conglomerate’s sales dipped to a nine month low in its latest earnings, which accompanied sweeping changes to leadership and the unveiling of its newest action plan.

The Ozempic maker’s shares rose after Novo withdrew from a $10 billion takeover battle with Pfizer over obesity drug developer Metsera.

The Ozempic maker’s shares rose after Novo withdrew from a $10 billion takeover battle with Pfizer over obesity drug developer Metsera.

The short answer is yes — but it won’t soon return to its pre-pandemic growth rates. After two years of turbulence, the market remains shaky, and brands will need to earn every sale.

The short answer is yes — but it won’t soon return to its pre-pandemic growth rates. After two years of turbulence, the market remains shaky, and brands will need to earn every sale.

The Japanese conglomerate and Bioré owner’s latest earnings show early gains from its new strategy to drive beauty growth.

The Japanese conglomerate and Bioré owner’s latest earnings show early gains from its new strategy to drive beauty growth.

A judge denied Pfizer’s request to temporarily block Novo Nordisk’s $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

A judge denied Pfizer’s request to temporarily block Novo Nordisk’s $10 billion bid to acquire the obesity startup Metsera Inc., saying the US pharmaceutical company’s objections to the deal don’t warrant a delay.

L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.

L’Oréal is set to take over the coveted Gucci license in a few short years, but losing a key brand is just one of the US conglomerate’s woes.
Givaudan’s second-quarter organic sales came in ahead of market estimates on Thursday, but its shares fell 5 percent on litigation costs and tariff repayments.
The move is the White House’s latest effort to restore Trump’s campaign vision of a near-global tariff after the US Supreme Court in February struck down his ‘reciprocal’ duties.
Givenchy executive Yann Musquin will lead the group’s fragrance portfolio, succeeding longtime division head Romain Spitzer.
In a major win for Amazon, which lobbied for the change, the government will allow foreign e-commerce companies to buy products directly from Indian sellers and sell them to overseas customers.
The dermatologist-developed label has named Nathalie Kristo as its first chief executive officer and Toral Patel as chief marketing officer.
Stone Island’s strong performance helped offset slower growth at the Moncler brand, as the group continues its push to become less dependent on its iconic winter outerwear.
The British luxury handbag maker reported a strong start to fiscal 2027 as CEO Andrea Baldo’s strategy gains traction and the brand gears up for designer Christopher Kane’s runway debut in September.
The designer departed his namesake label 3.1 Phillip Lim in November 2024 to pursue personal projects.